Literature DB >> 1500171

Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes.

K B Kenefick1, J A Lederer, R F Schell, C J Czuprynski.   

Abstract

Infection with Borrelia burgdorferi is suspected to be a cause of lameness and arthritis in cattle. Interleukin-1 (IL-1) activity has been detected in joint fluids from human patients affected by various arthritides, including Lyme arthritis. In addition, human monocytes and murine macrophages have been reported to release IL-1 activity when incubated with B. burgdorferi in vitro. To address a possible mechanism by which B. burgdorferi might cause a bovine arthritic syndrome, we determined whether bovine peripheral blood monocytes released IL-1 activity when coincubated with B. burgdorferi in vitro. High-passage and low-passage isolates of B. burgdorferi stimulated release of IL-1 activity from bovine monocytes. The amount of IL-1 activity released was dependent on the number of borreliae added to the monocyte cultures. In addition, live and heat-killed B. burgdorferi cells stimulated release of similar amounts of IL-1. We also obtained no evidence that soluble components released from in vitro-cultured B. burgdorferi stimulated IL-1 release from bovine monocytes. A recombinant IL-1 receptor antagonist blocked the proliferative activity of monocyte-conditioned medium in a thymocyte costimulation assay, thus demonstrating that the costimulatory activity detected was due to IL-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500171      PMCID: PMC257370          DOI: 10.1128/iai.60.9.3630-3634.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

2.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

3.  Spirochetes isolated from the blood of two patients with Lyme disease.

Authors:  J L Benach; E M Bosler; J P Hanrahan; J L Coleman; G S Habicht; T F Bast; D J Cameron; J L Ziegler; A G Barbour; W Burgdorfer; R Edelman; R A Kaslow
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

4.  Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.

Authors:  W J Simpson; W Burgdorfer; M E Schrumpf; R H Karstens; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells.

Authors:  K Georgilis; A C Steere; M S Klempner
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

Review 6.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

7.  Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats.

Authors:  J H Schwab; S K Anderle; R R Brown; F G Dalldorf; R C Thompson
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 8.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

Authors:  W P Arend
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  The modulation of lymphocyte functions by molecules secreted by macrophages. II. Conditions leading to increased secretion.

Authors:  E R Unanue; J M Kiely; J Calderon
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

Authors:  K W McIntyre; G J Stepan; K D Kolinsky; W R Benjamin; J M Plocinski; K L Kaffka; C A Campen; R A Chizzonite; P L Kilian
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  8 in total

1.  Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.

Authors:  B K Du Chateau; D M England; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.

Authors:  H Fuchs; M M Simon; R Wallich; M Bechtel; M D Kramer
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.

Authors:  Anna M Ritzman; Jennifer M Hughes-Hanks; Victoria A Blaho; Laura E Wax; William J Mitchell; Charles R Brown
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

4.  Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures.

Authors:  R K Straubinger; A F Straubinger; B A Summers; H N Erb; L Härter; M J Appel
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Fetal outcome in murine Lyme disease.

Authors:  R M Silver; L Yang; R A Daynes; D W Branch; C M Salafia; J J Weis
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.

Authors:  Y Ma; K P Seiler; K F Tai; L Yang; M Woods; J J Weis
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.